Early Phase 1 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 30 years of age
- People who have been diagnosed with moderate knee osteoarthritis (Grade II or III on a standard medical scale called the KL scale) in one knee
- People with a Body Mass Index (BMI) below 50 kg/m²
- People who rate their knee pain as 4 or higher out of 10 on a standard pain scale
- Women who are not sexually active, have had a surgical procedure to prevent pregnancy, or have gone through menopause
- Women who have not yet gone through menopause and have a negative pregnancy test, are using contraception, and do not plan to become pregnant during the study
- People who are willing and able to provide written consent to participate, in English
- People who are willing and able to follow all study requirements, attend visits, and communicate in English
Who may not be able to join:
- People who have taken any pain medications, including anti-inflammatory drugs (such as ibuprofen), within 2 weeks before the study injection date
- People who use blood-thinning medications, have a history of substance abuse, or are unwilling to agree to report any knee-related medications taken during the study to the research team
- People who have had any injection into the affected knee (including joint lubricant injections) in the past 6 months
- People who have had surgery on the affected knee in the past 6 months
- People who have had a traumatic injury to the affected knee in the past 3 months
- People who have planned surgery scheduled during the study period
- People with a history of organ or blood cell transplantation, rheumatoid arthritis, or other conditions where the immune system attacks the body
- People who are currently taking medications that suppress the immune system
- People who have been diagnosed with cancer in the past 2 years
- People who have a current knee infection or have used antibiotics for a knee infection in the past 3 months
- People who have participated in any other clinical trial or received any experimental treatment (for any health reason) in the past 30 days
- Women who are breastfeeding, currently pregnant, or plan to become pregnant during the study
- People for whom standard X-ray or MRI scans are not suitable (confirm with trial site)
- People with serious neurological, psychological, or psychiatric conditions
- People who have an active legal claim or compensation case related to an injury or disability
- People with a known allergy to any of these medications: amphotericin-B, ciprofloxacin, gentamycin, penicillin, or streptomycin
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
C Reactive Protein; Erythrocyte Sedimentation Rate; Alanine Transaminase; Aspartate Transaminase; Alkaline Phosphatase; Albumin; Creatinine; Blood Urea Nitrogen
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.